VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)

Clinical trial NCT05715125 · TERMINATED

Trial details

NCT number: NCT05715125
Sponsor: Ventyx Biosciences, Inc
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2023-01-31
Primary completion: 2024-01-02
Enrollment: 205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.